@article{ribrag:inserm-01419476,
TITLE = {Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial},
AUTHOR = {Ribrag, Vincent and Koscielny, Serge and Bosq, Jacques and Leguay, Thibaut and Casasnovas, Olivier and Fornecker, Luc-Mathieu and Recher, Christian and Ghesquieres, Herv{\'e} and Morschhauser, Franck and Girault, St{\'e}phane and Le Gouill, Steven and Ojeda-Uribe, Mario and Mariette, Clara and Cornillon, Jerome and Cartron, Guillaume and Verge, Veronique and Chassagne-Cl{\'e}ment, Catherine and Dombret, Herv{\'e} and Coiffier, Bertrand and Lamy, Thierry and Tilly, Herv{\'e} and Salles, Gilles},
URL = {https://inserm.hal.science/inserm-01419476},
JOURNAL = {The Lancet},
PUBLISHER = {Elsevier},
VOLUME = {387},
NUMBER = {10036},
PAGES = {2402 - 2411},
YEAR = {2016},
MONTH = Jun, DOI = {10.1016/S0140-6736(15)01317-3},
PDF = {https://inserm.hal.science/inserm-01419476/file/2016Art7BEq10.pdf},
HAL_ID = {inserm-01419476},
HAL_VERSION = {v1},
}